Evaluation of skin cancer screening in Germany – Spatiotemporal associations between skin cancer screening and skin cancer mortality based on ambulatory claims data
JDDG: Journal der Deutschen Dermatologischen Gesellschaft · 2023
DOI: 10.1111/ddg.15172 ↗Kurz gefasst
Fachartikel in der Zeitschrift JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2023. Verfasst von Sandra Wolf und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany. Hauptthemen laut MEDLINE: Early Detection of Cancer, Skin Neoplasms. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Innovation Fund of the Federal Joint Committee.
Abstract (Originalsprache)
Background
There are regional differences in skin cancer screening uptake in Germany. So far, it is unclear whether a high uptake of screening services leads to a reduction in mortality. This article presents study results on the investigation of spatiotemporal associations between skin cancer screening and mortality. The methods used are discussed regarding their suitability. Material and methods The basis is ambulatory claims data on the utilization of early skin cancer detection as well as data on skin cancer mortality from the cause‐of‐death statistics of the years 2011–2015 at county level in Germany. In addition to a descriptive evaluation, spatiotemporal cluster analyses and regression models were used to investigate the relationship between the uptake of early detection and mortality. In addition to age, adjustments were also made for other selected socio‐economic and socio‐graphical variables.
Results
The descriptive results show striking spatial patterns of skin cancer screening and mortality. Cluster analyses identified regions with significantly higher and lower cases of early detection and skin cancer mortality. The spatiotemporal regression analyses show no clear association. Only early detection by a dermatologist, adjusted for age, shows an association with mortality.
Conclusions
No clear association between early skin cancer detection and mortality can be derived from the results. However, the study design used with a spatiotemporal cluster and regression analysis has shown that these methods allow in‐depth statements about the relationship between early skin cancer detection and mortality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.
- Institute of Social Medicine and Epidemiology, University of Lübeck, Lübeck, Germany.
ORCID-Profile: Matthias Augustin, Kristina Hagenström, Jobst Augustin
Förderung
- Innovation Fund of the Federal Joint Committee
Zitieren
APA
Wolf, S., Augustin, M., Hagenström, K., Garbe, C., Baltus, H., Eisemann, N., Hübner, J., Katalinic, A., & Augustin, J. (2023). Evaluation of skin cancer screening in Germany – Spatiotemporal associations between skin cancer screening and skin cancer mortality based on ambulatory claims data. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. https://doi.org/10.1111/ddg.15172
Vancouver
Wolf S, Augustin M, Hagenström K, Garbe C, Baltus H, Eisemann N, et al. Evaluation of skin cancer screening in Germany – Spatiotemporal associations between skin cancer screening and skin cancer mortality based on ambulatory claims data. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 2023. doi:10.1111/ddg.15172
BibTeX
@article{Wolf2023,
author = {Wolf, Sandra and Augustin, Matthias and Hagenström, Kristina and Garbe, Claudia and Baltus, Hannah and Eisemann, Nora and Hübner, Joachim and Katalinic, Alexander and Augustin, Jobst},
title = {Evaluation of skin cancer screening in Germany – Spatiotemporal associations between skin cancer screening and skin cancer mortality based on ambulatory claims data},
journal = {JDDG: Journal der Deutschen Dermatologischen Gesellschaft},
year = {2023},
doi = {10.1111/ddg.15172}
}
EUVIMED